Cargando…
Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses
African swine fever (ASF) is a highly lethal infectious disease that affects domestic pigs and wild boar. Outbreaks of ASF have grown considerably in the last decade causing important economic consequences for the swine industry. Its control is hampered by the lack of an effective treatment or vacci...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669561/ https://www.ncbi.nlm.nih.gov/pubmed/34917082 http://dx.doi.org/10.3389/fimmu.2021.761753 |
_version_ | 1784614804652032000 |
---|---|
author | Barasona, Jose A. Cadenas-Fernández, Estefanía Kosowska, Aleksandra Barroso-Arévalo, Sandra Rivera, Belén Sánchez, Rocío Porras, Néstor Gallardo, Carmina Sánchez-Vizcaíno, Jose M. |
author_facet | Barasona, Jose A. Cadenas-Fernández, Estefanía Kosowska, Aleksandra Barroso-Arévalo, Sandra Rivera, Belén Sánchez, Rocío Porras, Néstor Gallardo, Carmina Sánchez-Vizcaíno, Jose M. |
author_sort | Barasona, Jose A. |
collection | PubMed |
description | African swine fever (ASF) is a highly lethal infectious disease that affects domestic pigs and wild boar. Outbreaks of ASF have grown considerably in the last decade causing important economic consequences for the swine industry. Its control is hampered by the lack of an effective treatment or vaccine. In Europe, the wild boar is a key wild reservoir for ASF. The results of the oral vaccination trial of wild boar with Lv17/WB/Rie1 are hope for this problem. However, this vaccine candidate has certain safety concerns, since it is a naturally attenuated vaccine. Therefore, the current study aims to evaluate the safety of this vaccine candidate in terms of overdose (high dose) and repeated doses (revaccination) in wild boar. Low-dose orally vaccinated animals developed only a slight transient fever after vaccination and revaccination. This was also the case for most of the high-dose vaccinated wild boar, except for one of them which succumbed after revaccination. Although this fatality was related to hierarchical fights between animals, we consider that further studies are required for clarification. Considering these new results and the current epidemiological situation of ASF in wild boar, this vaccine prototype is a promising tool for the control of the disease in these wild populations, although further studies are needed. |
format | Online Article Text |
id | pubmed-8669561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86695612021-12-15 Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses Barasona, Jose A. Cadenas-Fernández, Estefanía Kosowska, Aleksandra Barroso-Arévalo, Sandra Rivera, Belén Sánchez, Rocío Porras, Néstor Gallardo, Carmina Sánchez-Vizcaíno, Jose M. Front Immunol Immunology African swine fever (ASF) is a highly lethal infectious disease that affects domestic pigs and wild boar. Outbreaks of ASF have grown considerably in the last decade causing important economic consequences for the swine industry. Its control is hampered by the lack of an effective treatment or vaccine. In Europe, the wild boar is a key wild reservoir for ASF. The results of the oral vaccination trial of wild boar with Lv17/WB/Rie1 are hope for this problem. However, this vaccine candidate has certain safety concerns, since it is a naturally attenuated vaccine. Therefore, the current study aims to evaluate the safety of this vaccine candidate in terms of overdose (high dose) and repeated doses (revaccination) in wild boar. Low-dose orally vaccinated animals developed only a slight transient fever after vaccination and revaccination. This was also the case for most of the high-dose vaccinated wild boar, except for one of them which succumbed after revaccination. Although this fatality was related to hierarchical fights between animals, we consider that further studies are required for clarification. Considering these new results and the current epidemiological situation of ASF in wild boar, this vaccine prototype is a promising tool for the control of the disease in these wild populations, although further studies are needed. Frontiers Media S.A. 2021-11-30 /pmc/articles/PMC8669561/ /pubmed/34917082 http://dx.doi.org/10.3389/fimmu.2021.761753 Text en Copyright © 2021 Barasona, Cadenas-Fernández, Kosowska, Barroso-Arévalo, Rivera, Sánchez, Porras, Gallardo and Sánchez-Vizcaíno https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Barasona, Jose A. Cadenas-Fernández, Estefanía Kosowska, Aleksandra Barroso-Arévalo, Sandra Rivera, Belén Sánchez, Rocío Porras, Néstor Gallardo, Carmina Sánchez-Vizcaíno, Jose M. Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses |
title | Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses |
title_full | Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses |
title_fullStr | Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses |
title_full_unstemmed | Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses |
title_short | Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses |
title_sort | safety of african swine fever vaccine candidate lv17/wb/rie1 in wild boar: overdose and repeated doses |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669561/ https://www.ncbi.nlm.nih.gov/pubmed/34917082 http://dx.doi.org/10.3389/fimmu.2021.761753 |
work_keys_str_mv | AT barasonajosea safetyofafricanswinefevervaccinecandidatelv17wbrie1inwildboaroverdoseandrepeateddoses AT cadenasfernandezestefania safetyofafricanswinefevervaccinecandidatelv17wbrie1inwildboaroverdoseandrepeateddoses AT kosowskaaleksandra safetyofafricanswinefevervaccinecandidatelv17wbrie1inwildboaroverdoseandrepeateddoses AT barrosoarevalosandra safetyofafricanswinefevervaccinecandidatelv17wbrie1inwildboaroverdoseandrepeateddoses AT riverabelen safetyofafricanswinefevervaccinecandidatelv17wbrie1inwildboaroverdoseandrepeateddoses AT sanchezrocio safetyofafricanswinefevervaccinecandidatelv17wbrie1inwildboaroverdoseandrepeateddoses AT porrasnestor safetyofafricanswinefevervaccinecandidatelv17wbrie1inwildboaroverdoseandrepeateddoses AT gallardocarmina safetyofafricanswinefevervaccinecandidatelv17wbrie1inwildboaroverdoseandrepeateddoses AT sanchezvizcainojosem safetyofafricanswinefevervaccinecandidatelv17wbrie1inwildboaroverdoseandrepeateddoses |